1. Home
  2. THRD vs NRDY Comparison

THRD vs NRDY Comparison

Compare THRD & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • NRDY
  • Stock Information
  • Founded
  • THRD 2019
  • NRDY 2007
  • Country
  • THRD United States
  • NRDY United States
  • Employees
  • THRD N/A
  • NRDY N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • NRDY Computer Software: Prepackaged Software
  • Sector
  • THRD Health Care
  • NRDY Technology
  • Exchange
  • THRD Nasdaq
  • NRDY Nasdaq
  • Market Cap
  • THRD 238.7M
  • NRDY 206.0M
  • IPO Year
  • THRD 2022
  • NRDY N/A
  • Fundamental
  • Price
  • THRD $5.42
  • NRDY $1.57
  • Analyst Decision
  • THRD Hold
  • NRDY Hold
  • Analyst Count
  • THRD 3
  • NRDY 8
  • Target Price
  • THRD $5.00
  • NRDY $1.90
  • AVG Volume (30 Days)
  • THRD 251.2K
  • NRDY 568.6K
  • Earning Date
  • THRD 08-07-2025
  • NRDY 08-07-2025
  • Dividend Yield
  • THRD N/A
  • NRDY N/A
  • EPS Growth
  • THRD N/A
  • NRDY N/A
  • EPS
  • THRD N/A
  • NRDY N/A
  • Revenue
  • THRD N/A
  • NRDY $184,099,000.00
  • Revenue This Year
  • THRD N/A
  • NRDY $4.60
  • Revenue Next Year
  • THRD N/A
  • NRDY $9.97
  • P/E Ratio
  • THRD N/A
  • NRDY N/A
  • Revenue Growth
  • THRD N/A
  • NRDY N/A
  • 52 Week Low
  • THRD $3.18
  • NRDY $0.73
  • 52 Week High
  • THRD $16.02
  • NRDY $2.18
  • Technical
  • Relative Strength Index (RSI)
  • THRD 68.70
  • NRDY 43.08
  • Support Level
  • THRD $5.41
  • NRDY $1.51
  • Resistance Level
  • THRD $5.52
  • NRDY $1.90
  • Average True Range (ATR)
  • THRD 0.05
  • NRDY 0.08
  • MACD
  • THRD -0.01
  • NRDY -0.02
  • Stochastic Oscillator
  • THRD 64.29
  • NRDY 15.38

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.

Share on Social Networks: